Molecule2Market is a team of expert clinical research professionals dedicated to advancing Australia’s contribution to the research and development of innovative medical treatments. Our directors have accumulated over 50 years experience in the development of life-changing medical innovations. Our team of expert clinical trial consultants and professionals each have a minimum of 15 years of experience, with most having acquired over 20 years of experience working in the field.


Our USA business team values working collaboratively with our local and international Customers and strives to maintain a true partnership with them. As a partner, we are more than just a service provider, our desire is to be an extension of our customers, where we will passionately invest ourselves in their program with the same vigor and energy that would be expected from the Customers team members. Our great Customer relationships are underscored by trust, communication, accountability, mutual respect, and an aligned desire for success. Our USA business team is noted for their attention to detail and our flat organizational structure which provides Customers with easy access to our leadership team including George Zafiris. George has greater than 21 years of experience across all facets of clinical research in multiple therapeutic areas and has a passion for pediatric and rare disease studies as well as research in neurology, infectious diseases and oncology.


A privately owned Australian CRO (Clinical Research Organisation), we provide consulting services to the pharmaceutical and biotechnology industries to perform clinical research within Australia and extending to the Asia Pacific region. M2M’s clinical research services support Australia’s top tier medical research and healthcare industry. As a base of operations, Australia offers a multitude of benefits for companies conducting clinical trials and obtaining regulatory approval for their life-changing products. These benefits include but are not limited to efficient ethics and regulatory approval (60-90 days average approval period) and research and development (R&D) tax incentives.


Combining the strength of our expertise and extensive experience, we provide premium services across all phases of clinical research in a broad range of therapeutic areas. For years we have been offering our partners regulatory and medical writing, clinical trial management across all phases, quality assurance/auditing, medical monitoring, data management and statistics support.


Our network of partners and affiliates cover multiple regulatory areas including Europe, USA, Canada, Africa and Asia giving us access to a deep pool of knowledge and ensuring we keep up to date regarding the latest advancements in CRO services. The team that will handle your project comes from diverse backgrounds including pharmaceuticals, health care professionals and scientists with extensive years of experience in all phases of clinical trials resulting in the development of innovative treatments.


M2M assists medical innovations to progress efficiently through the clinical trials process to achieve registration, so they can be available to people that are in dire need of them. Our team of specialist clinical research professionals will support your efforts in all areas necessary to get your life-saving products to market.


We use our extensive years of experience to your benefit; there are few obstacles that we have not encountered and overcome while offering clinical research services to our clients. Our team knows how to quickly, ethically and efficiently navigate the complexities involved in the development of life-changing innovations.


  • Project Feasibility: Clinical trial feasibility will evaluate the ability for your clinical research to be performed in a way that achieves your timeframe and cost targets.
  • Site Selection: This step is a crucial part of ensuring your clinical trials are conducted and completed within budget, to the highest standards and on schedule. Clinical sites in Australia, New Zealand and the USA are high-quality facilities, staffed with industry-leading professionals that frequently participate in demanding clinical trials.
  • Study Start-up (including ethics/IRB submissions and contract and budget negotiation): Our team will ensure your project meets the requirements necessary to launch your study. We will ensure that your study start-up process is done quickly and in a cost-effective way.
  • Monitoring: M2M’s clinical trials services ensure the ethical, successful and efficient completion of your clinical research.
  • Project Management: The team at M2M will take on your contract from the initial stages to the final steps. No need to develop your own costly infrastructure, or dedicate the extensive labour hours necessary to learn how to navigate the regulatory landscape, we will do it for you.
  • Subject Recruitment: Subject recruitment is a time-intensive and crucial part of a successful clinical trial. We will ensure that this process is performed in an ethical and efficient way to yield the best results and data. 
  • Local Safety Reporting: With M2M you are accessing a deep repository of knowledge regarding regulatory requirements required for the successful development and research of medical innovations. Our team has been involved in all the stages, across multiple clinical trials required for the successful development and research of medical innovations.
  • Quality Management (quality review and audit preparation, inspection readiness audits): We will oversee and ensure all quality standards are met when conducting your clinical trials.
  • Site Closeout: Upon completion of your clinical trials, we will reconcile, record, and report all related activities in accordance with protocols set forth by the applicable local and international regulatory bodies.


Our clinical research services support the delivery of crucial, life-changing treatments to people that need them. Clinical trials and regulatory approval are imperative to the successful development of these treatments, which is why we use our wealth of experience in a multitude of therapeutic areas to make this extensive process as efficient as possible.

Our Partners

  • arcs
  • dia
  • biomelbourne
  • biotech


“I now consider Robin, Anne and their team my first reach of engagement for domestic and international clients seeking the services they provide. I believe it is near impossible to capture the strength of my recommendation in favour of engagement with M2M in this brief email; but I will simply say this, if your initiative is of critical importance to your brand, firm or both, then I cannot think of a better team than M2M to turn to for service and support.”

Meso Consulting


We contracted M2M to provide clinical support for the set-up of a Phase II study of a new treatment for kidney disease. We found M2M to be professional and organised in the provision of contracted activities. They were able to provide practical advice to support us during this phase, and we appreciated their responsiveness.

General Manager, Dimerix Bioscience Pty Ltd


“We required site management and clinical monitoring support for an international hepatic study. M2M provided an experienced and professional team to cover all Australian sites. Their work is high quality, thorough and professional; we found M2M to be very accommodating and flexible regarding changes to sponsor set up and the addition of new study sites.
We would very much welcome the opportunity to work with M2M again in the future.”

Principal, Clinical Development
Medicines Development Ltd.


M2M provided excellent project management and monitoring support across 3 clinical trials for Roche during 2012 and 2013. The team were professional, efficient and flexible and were a pleasure to work with.

Clinical Research Manager, Clinical Operations , Roche Products Pty Limited


“Molecule2Market is a true partner to us and was a critical contributor to our feasibility and site selection in Australia. The Molecule2Market team continues to show passion and integrity in their support our study on its path towards site activation and on-time delivery of first patient in. Managing studies in Australia from the East Coast of USA can be challenging, but the Molecule2Market team make it easy by being responsive and available whether communication is by email, phone or other medium”

Clinical Project Director
Paidion Research, Inc.


Having conducted 4 trials with Molecule2Market since 2017, we have found them to be very supportive and responsive to us as a site. When we encountered some difficulties with specific procedures in the protocol, they were quick to come up with solutions and help us actively problem-solve. From start-up to close out, they provided regular updates and clear, timely communication. They were very appreciative of our efforts as a site and accommodated our requests where possible. It has been exciting to see their growth as a CRO, and we look forward to working with the M2M team on the next trial! 

Director, Clinical Trial Unit (Griffith Health)


It is rare that you can find a CRO partner that has such extensive experience, adapts to the needs of a sponsor and is so collaborative. M2M was that CRO for us on a study that was critical to the success of our organization. Their ability to work across multiple countries and effectively manage complex situations with other vendors enabled us to meet very challenging timelines. We put a lot of trust in their ability to execute and they did not let us down."

VP, Clinical Operations